| Literature DB >> 33809763 |
Amrit Pal Kaur1, Sonali Bhardwaj2, Daljeet Singh Dhanjal2, Eugenie Nepovimova3, Natália Cruz-Martins4,5,6, Kamil Kuča3, Chirag Chopra2, Reena Singh2, Harsh Kumar1, Fatih Șen7, Vinod Kumar8, Rachna Verma9, Dinesh Kumar1.
Abstract
Prebiotics are either natural or synthetic non-digestible (non-)carbohydrate substances that boost the proliferation of gut microbes. Undigested fructooligosaccharides in the large intestine are utilised by the beneficial microorganisms for the synthesis of short-chain fatty acids for their own growth. Although various food products are now recognized as having prebiotic properties, several others, such as almonds, artichoke, barley, chia seeds, chicory, dandelion greens, flaxseeds, garlic, and oats, are being explored and used as functional foods. Considering the benefits of these prebiotics in mineral absorption, metabolite production, gut microbiota modulation, and in various diseases such as diabetes, allergy, metabolic disorders, and necrotising enterocolitis, increasing attention has been focused on their applications in both food and pharmaceutical industries, although some of these food products are actually used as food supplements. This review aims to highlight the potential and need of these prebiotics in the diet and also discusses data related to the distinct types, sources, modes of action, and health benefits.Entities:
Keywords: dietary fiber; non-digestible carbohydrates; oligosaccharides; prebiotics; short-chain fatty acids
Year: 2021 PMID: 33809763 PMCID: PMC8002343 DOI: 10.3390/biom11030440
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Types, structure, production, and potential benefits of prebiotics.
| Types of Prebiotics | Chemical Structure | Production Methods | Potential Benefits | Reference |
|---|---|---|---|---|
| Fructooligosaccharides (FOS) | Glucose and Fructose units linked by β (2→1) glycosidic linkages | Polymerization of fructose monomers | Improve mineral absorption, decrease triglycerides, improve immunity, inhibit pathogenic microorganisms, prevent cancer, and control diabetes | [ |
| Galactooligosaccharides (GOS) | Galactose and Glucose bound by β (1→3) and β (1→4) linkages | Transgalactosylation of lactose using β-galactosidase | Increase bifidogenic activity | [ |
| Xylooligosaccharides (XOS) | xylose units linked through β (1→4) bonds | Enzymatic hydrolysis of plant xylans | Non-carcinogenic nature, exhibit a positive effect on the intestinal flora, non-digestibility | [ |
| Soybean oligosaccharides (SOS) | galactose α-(1-6) linked to glucose (Raffinose)galactose α-(1-6) linked to terminal galactose (Stachyose) | NS | Increase the level of IgG, modulate body weight and the immune system | [ |
| Isomalto-oligosaccharides (IMO) | Glucose bonds by α (1→4) type | Transglucosylation of liquefied starch | Improve gastrointestinal flora | [ |
| Fructans | fructose with β (2→1) linkage | Enzymatic hydrolysis using Fructozyme L | Modulate gut physiology to provide protection from pathogens, improve the level of glucose | [ |
| Guar gum | β-D-mannopyranosyl (1-4) linked with α-D-galactopyranosyl (1-6) residues | Enzymatic hydrolysis using cellulase | Improve cholesterol, glycemia | [ |
| Pectinoligosaccharides (POS) | (1-4)-α-D-GalA (galacturonic acid) -(1,2)-α-L-Rha | Enzymatic hydrolysis by pectinase | Anti-inflammatory effect | [ |
NS, not specified.
Figure 1Diagrammatic illustration of sources and functions of prebiotics.
Figure 2Effects of prebiotics on different organs in humans.